Youngjin Kim

Youngjin Kim

Auto-generated profile, based on publicly available information

Youngjin Kim

Department of General Surgery, Konyang University Hospital, Daejeon 35365, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2024 in Annals of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Open access
PDF file
SHSuk Kyun Hong
Suk Kyun Hong
MKMinseob Kim
Minseob Kim
YKYoungjin Kim
Youngjin Kim
JKJae-Yoon Kim
Jae-Yoon Kim
JLJaewon Lee
Jaewon Lee
KSKyung Su Suh
Kyung Su Suh
Suk Kyun Hong, Minseob Kim, Youngjin Kim, Jae-Yoon Kim, Jaewon Lee, Jiyoung Kim, Su Young Hong, Jeong-Moo Lee, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh. Ann Hepatobiliary Pancreat Surg 2024;28:337-43. https://doi.org/10.14701/ahbps.24-020

25 May 2023 in Annals of Liver Transplantation
Verified
Journal Article
Open access
PDF file
SHSuk Kyun Hong
Suk Kyun Hong
MKMinseob Kim
Minseob Kim
YKYoungjin Kim
Youngjin Kim
JKJaeyoon Kim
Jaeyoon Kim
HCHyun Hwa Choi
Hyun Hwa Choi
KSKyung Su Suh
Kyung Su Suh
Suk Kyun Hong, Minseob Kim, Youngjin Kim, Jaeyoon Kim, Hyun Hwa Choi, Jaewon Lee, Jiyoung Kim, Su young Hong, Jeong-Moo Lee, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.23.0010

Verified
Journal Article
Open access
PDF file
TSTae-Yun Sung
Tae-Yun Sung
YKYoungjin Kim
Youngjin Kim
JJJi-Yoon Jung
Ji-Yoon Jung
Background/Objectives: Postoperative nausea and vomiting (PONV) remain frequent after breast surgery despite prophylaxis. This single-center, parallel-group randomized controlled trial evaluated whether intraoperative opioid-sparing anesthesia using dexmedetomidine and lidocaine reduced 48 h PONV compared with opioid-based anesthesia. Methods: Adult women undergoing elective breast surgery were randomized 1:1 to opioid-sparing anesthesia with dexmedetomidine and lidocaine or conventional opioid-based anesthesia with remifentanil. Participants and postoperative outcome assessors were blinded to group allocation; attending anesthesiologists were not blinded. All patients received standardized sevoflurane anesthesia, dexamethasone, ramosetron, quantitative neuromuscular monitoring, and postoperative fentanyl patient-controlled analgesia. The primary outcome was PONV within 48 h after surgery. Results: Among 68 randomized patients, 67 were analyzed (opioid-sparing group, n = 33; control group, n = 34). PONV within 48 h occurred in 8 patients (24.2%) in the opioid-sparing group and 28 patients (82.4%) in the control group (risk ratio, 0.29; 95% confidence interval, 0.16–0.55; p < 0.001; absolute risk reduction, 58.1%; number needed to treat, 1.7). Rescue antiemetic use was lower in the opioid-sparing group in the postanesthesia care unit and at 1 h postoperatively. Pain scores and cumulative opioid consumption were comparable. No Clavien–Dindo grade III or higher complications occurred. Conclusions: Intraoperative opioid-sparing anesthesia was associated with lower 48 h PONV after breast surgery without apparent compromise in analgesia. These single-center findings, from a trial registered after enrollment of one participant, require confirmation in larger prospectively registered multicenter trials. Trial Registration: Clinical Research Information Service (CRIS), KCT0009829. Registered on 10 October 2024.

30 November 2023 in Annals of Liver Transplantation
Verified
Journal Article
Open access
PDF file
MKMinseob Kim
Minseob Kim
YKYoungjin Kim
Youngjin Kim
JKJae-Yoon Kim
Jae-Yoon Kim
JLJaewon Lee
Jaewon Lee
JKJiyoung Kim
Jiyoung Kim
KSKyung Su Suh
Kyung Su Suh
Suk Kyun Hong, Minseob Kim, Youngjin Kim, Jae-Yoon Kim, Jaewon Lee, Jiyoung Kim, Su young Hong, Jeong-Moo Lee, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh. Ann Liver Transplant 2023;3:94-9. https://doi.org/10.52604/alt.23.0015

1 January 2026 in Journal of Metabolic and Bariatric Surgery
Verified
Journal Article
Open access
SKSung Gon Kim
Sung Gon Kim
SLSang-Eok Lee
Sang-Eok Lee
DYDae Sung Yoon
Dae Sung Yoon
ICIn Seok Choi
In Seok Choi
JMJu Ik Moon
Ju Ik Moon
YKYoungjin Kim
Youngjin Kim
Metabolic and bariatric surgery (MBS) is an effective treatment for severe obesity and its related comorbidities. However, the long-term success and safety of these procedures depend heavily on continuous postoperative follow-up. Postoperative follow-up during the first year is essential for detecting surgical complications, monitoring weight loss trajectories, and optimizing nutritional status. Long-term follow-up is equally important for preventing weight regain, micronutrient deficiencies and recurrence of metabolic diseases. Structured and lifelong follow-up is a fundamental component of successful MBS. Despite recommendations from international societies, adherence to structured follow-up remains inconsistent in real-world practice. This review summarizes current evidence on optimal follow-up strategies after MBS, focusing on nutritional monitoring, management of complications, metabolic surveillance, psychosocial support, and multidisciplinary care.

15 May 2026 in Clinical Transplantation
Verified
Journal Article
Closed access
YKYoungjin Kim
Youngjin Kim
KLKwang-Woong Lee
Kwang-Woong Lee
YCYoungRok Choi
YoungRok Choi
SHSu Young Hong
Su Young Hong
SHSuk Kyun Hong
Suk Kyun Hong